CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 350

Industry reads hand-picked by our editors

Sep 01, 2015

Forbes
Biotech stock bulls see cause for caution, not a stop sign
Bloomberg
Robot millionaire takes a shot at fixing severed spines
FierceBiotech
Amicus bags phase III rare disease drug in $847 million Scioderm buyout

Aug 31, 2015

Boston Globe
The return of Ed Silverman's Pharmalot
Reuters
Bayer heart failure med cuts deaths in mid-stage trial
24/7 Wall Street
5 top earnings for the week ahead

Aug 28, 2015

Bloomberg
Mylan investors vote to push ahead with hostile Perrigo deal
Reuters
U.S. vaccination rates high, but pockets of unvaccinated pose risk
in-PharmaTechnologist
Scientists build 'microfish' robots for controlled drug delivery

Aug 27, 2015

Reuters
Life expectancy increases may come with quality of life decreases
Bloomberg
Abbott Labs denies report that it's preparing for a St. Jude Medical bid
Reuters
FDA wants food companies to hand over pathogens for genomic sequencing, testing

Aug 26, 2015

Reuters
Novo launching phase III for major diabetes hopeful
Bloomberg
Sucampo Pharma to make tender offer for Japan's R-Tech Ueno
Reuters
Use of statins rising among very elderly

Aug 25, 2015

Reuters
Rhode Island move to mandate HPV vaccine in schools faces criticism
Bloomberg
Kyle Bass' challenge to two Acorda drug patents rejected
WSJ
VA disability claims backlog fall to 8-year low

Aug 24, 2015

Reuters
AstraZeneca hires Genetech vet as chief medical officer
WSJ
China worries could hurt pharma's health
Reuters
Vital Therapies crashes after liver trial fails

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.